112
Views
7
CrossRef citations to date
0
Altmetric
Review

Relationship between nonalcoholic fatty liver disease and bone mineral density in adolescents with obesity: a meta-analysis

, , , , , & show all
Pages 199-207 | Published online: 30 Jan 2019

References

  • Chalasani N Younossi Z Lavine JE The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology Gastroenterology 2012 142 7 1592 1609 22656328
  • Rinella M Charlton M Mary R The globalization of nonalcoholic fatty liver disease: prevalence and impact on world health Hepatology 2016 64 1 19 22 26926530
  • Welsh JA Karpen S Vos MB Saul K Increasing prevalence of nonalcoholic fatty liver disease among United States adolescents, 1988-1994 to 2007-2010 J Pediatr 2013 162 3 496 500 23084707
  • Burt AD Lackner C Tiniakos DG Burt Alastair D Carolin L Diagnosis and assessment of NAFLD: definitions and histopathological classification Semin Liver Dis 2015 35 3 207 220 26378639
  • Nobili V Svegliati-Baroni G Alisi A Miele L Valenti L Vajro P A 360-degree overview of paediatric NAFLD: recent insights J Hepatol 2013 58 6 1218 1229 23238106
  • Korean Association for the Study of the Liver (KASL) KASL clinical practice guidelines: management of nonalcoholic fatty liver disease Clin Mol Hepatol 2013 19 4 325 348 24459637
  • Alkhater SA Paediatric non-alcoholic fatty liver disease: an overview Obes Rev 2015 16 5 393 405 25753407
  • Méndez-Sánchez N Arrese M Zamora-Valdés D Uribe M Nahum M-S Daniel Z-V Current concepts in the pathogenesis of nonalcoholic fatty liver disease Liver Int 2007 27 4 423 433 17403181
  • Italian Association for the Study of the Liver (AISF) AISF position paper on nonalcoholic fatty liver disease (NAFLD): updates and future directions Dig Liver Dis 2017 49 5 471 483 28215516
  • Umehara T Toshihiro U Nonalcoholic fatty liver disease with elevated alanine aminotransferase levels is negatively associated with bone mineral density: cross-sectional study in U.S. adults PLoS One 2018 13 6 e0197900 29897928
  • Sözen T Özışık L BaşaranBaşaran NÇ Tümay S Lale Özışık Çalık BN An overview and management of osteoporosis Eur J Rheumatol 2017 4 1 46 56 28293453
  • Yamamoto K Definition and diagnostic criteria of osteoporosis in Japan Clin Calcium 2001 11 1 19 24 15775485
  • Cosman F de Beur SJ Leboff MS Clinician’s guide to prevention and treatment of osteoporosis Osteoporos Int 2014 25 10 2359 2381 25182228
  • Wade SW Strader C Fitzpatrick LA Anthony MS O’Malley CD Estimating prevalence of osteoporosis: examples from industrialized countries Arch Osteoporos 2014 9 1 182 24847682
  • Cummings SR Melton LJ Joseph ML Epidemiology and outcomes of osteoporotic fractures Lancet 2002 359 9319 1761 1767 12049882
  • Videira-Silva A Sardinha L Fonseca H Antonio V-S Effect of a physical activity consultation in the management of adolescent overweight (the PAC-MAnO project): study rationale, design and methods BMJ Paediatr Open 2018 2 1 e000214
  • Sardinha LB Santos R Vale S Prevalence of overweight and obesity among Portuguese youth: a study in a representative sample of 10-18-year-old children and adolescents Int J Pediatr Obes 2011 6 2–2 e124 e128 20919807
  • Inchley J Currie D Jewell J Adolescent Obesity and Related Behaviours: Trends and Inequalities in the WHO European Region; 2002–2014 Geneva World Health Organization 2017
  • Pardee PE Dunn W Schwimmer JB Non-alcoholic fatty liver disease is associated with low bone mineral density in obese children Aliment Pharmacol Ther 2012 35 2 248 254 22111971
  • Purnak T Beyazit Y Ozaslan E Efe C Hayretci M The evaluation of bone mineral density in patients with nonalcoholic fatty liver disease Wien Klin Wochenschr 2012 124 15–16 526 531 22850810
  • Cui R Sheng H Rui XF Low bone mineral density in Chinese adults with nonalcoholic fatty liver disease Int J Endocrinol 2013 2013 396545 23983685
  • Poggiogalle E Donini LM Lenzi A Chiesa C Pacifico L Non-alcoholic fatty liver disease connections with fat-free tissues: a focus on bone and skeletal muscle World J Gastroenterol 2017 23 10 1747 1757 28348479
  • Liberati A Altman DG Tetzlaff J The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration J Clin Epidemiol 2009 62 10 e1 34 19631507
  • Tanner JM Whitehouse RH Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty Arch Dis Child 1976 51 3 170 179 952550
  • Stang A Andreas S Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses Eur J Epidemiol 2010 25 9 603 605 20652370
  • Cochran WG The combination of estimates from different experiments Biometrics 1954 10 1 101 129
  • Shachar M Meta-analysis: the preferred method of choice for the assessment of distance learning quality factors IRRODL 2008 9 3 1 15
  • Dersimonian R Laird N Meta-analysis in clinical trials Control Clin Trials 1986 7 3 177 188 3802833
  • Handzlik-Orlik G Holecki M Wilczyński K Duława J Osteoporosis in liver disease: pathogenesis and management Ther Adv Endocrinol Metab 2016 7 3 128 135 27293541
  • Li M Xu Y Xu M Association between nonalcoholic fatty liver disease (NAFLD) and osteoporotic fracture in middle-aged and elderly Chinese J Clin Endocrinol Metab 2012 97 6 2033 2038 22466338
  • Moon SS Lee YS Kim SW Seong-Su M Association of nonalcoholic fatty liver disease with low bone mass in postmenopausal women Endocrine 2012 42 2 423 429 22407492
  • Guañabens N Parés A Núria G Albert P Osteoporosis in chronic liver disease Liver Int 2018 38 5 776 785 29479832
  • Ozgur P Huseyin B Ismet T Correlation of insulin sensitivity with bone mineral status in obese adolescents with nonalcoholic fatty liver disease Clin Endocrinol 2011 75 189 195
  • Campos RMS de Piano A da Silva PL The role of pro/anti-inflammatory adipokines on bone metabolism in NAFLD obese adolescents: effects of long-term interdisciplinary therapy Endocrine 2012 42 1 146 156 22315014
  • Aigner E Theurl I Theurl M Pathways underlying iron accumulation in human nonalcoholic fatty liver disease Am J Clin Nutr 2008 87 5 1374 1383 18469261
  • Manco M Marcellini M Giannone G Nobili V Correlation of serum TNF-alpha levels and histologic liver injury scores in pediatric nonalcoholic fatty liver disease Am J Clin Pathol 2007 127 6 954 960 17509993
  • Morimoto J Kon S Matsui Y Uede T Junko M Shigeyuki K Osteopontin; as a target molecule for the treatment of inflammatory diseases Curr Drug Targets 2010 11 4 494 505 20196720
  • Yilmaz Y Yonal O Kurt R Serum levels of osteoprotegerin in the spectrum of nonalcoholic fatty liver disease Scand J Clin Lab Invest 2010 70 8 541 546 20942739
  • Yilmaz Y Kurt R Eren F Imeryuz N Serum osteocalcin levels in patients with nonalcoholic fatty liver disease: association with ballooning degeneration Scand J Clin Lab Invest 2011 71 8 631 636 21859358
  • Haukeland JW Dahl TB Yndestad A Fetuin A in nonalcoholic fatty liver disease: in vivo and in vitro studies Eur J Endocrinol 2012 166 3 503 510 22170794
  • Yilmaz Y Yonal O Kurt R Serum fetuin A/α2HS-glycoprotein levels in patients with non-alcoholic fatty liver disease: relation with liver fibrosis Ann Clin Biochem 2010 47 Pt 6 549 553 20926473
  • Reinehr T Roth CL Thomas R Fetuin-A and its relation to metabolic syndrome and fatty liver disease in obese children before and after weight loss J Clin Endocrinol Metab 2008 93 11 4479 4485 18728159
  • Kudo O Fujikawa Y Itonaga I Sabokbar A Torisu T Athanasou NA Proinflammatory cytokine (TNFalpha/IL-1alpha) induction of human osteoclast formation J Pathol 2002 198 2 220 227 12237882
  • Gilbert L He X Farmer P Expression of the osteoblast differentiation factor RUNX2 (Cbfa1/AML3/Pebp2alpha A) is inhibited by tumor necrosis factor-alpha J Biol Chem 2002 277 4 2695 2701 11723115
  • Haley B Pegah G Younossi Zobair M Pediatric non-alcoholic fatty liver disease Children 2017 4 6
  • Yilmaz Y Review article: non-alcoholic fatty liver disease and osteoporosis – clinical and molecular crosstalk Aliment Pharmacol Ther 2012 36 4 345 352 22730920
  • Cai D Yuan M Frantz DF Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB Nat Med 2005 11 2 183 190 15685173
  • Betancourt-Garcia MM Arguelles A Montes J Hernandez A Singh M Forse RA Pediatric nonalcoholic fatty liver disease: the rise of a lethal disease among Mexican American Hispanic children Obes Surg 2017 27 1 236 244 27822768
  • Schwimmer JB Deutsch R Kahen T Lavine JE Stanley C Behling C Prevalence of fatty liver in children and adolescents Pediatrics 2006 118 4 1388 1393 17015527
  • Venn AJ Thomson RJ Schmidt MD Overweight and obesity from childhood to adulthood: a follow-up of participants in the 1985 Australian Schools Health and Fitness Survey Med J Aust 2007 186 9 458 460 17484707
  • Ogden CL Carroll MD Kit BK Flegal KM Prevalence of childhood and adult obesity in the United States, 2011-2012 JAMA 2014 311 8 806 814 24570244
  • Simmonds M Burch J Llewellyn A The use of measures of obesity in childhood for predicting obesity and the development of obesity-related diseases in adulthood: a systematic review and meta-analysis Health Technol Assess 2015 19 1 336
  • Baxter-Jones AD Mirwald RL McKay HA Bailey DA A longitudinal analysis of sex differences in bone mineral accrual in healthy 8-19-year-old boys and girls Ann Hum Biol 2003 30 2 160 175 12637192
  • Ferretti JL Capozza RF Cointry GR Gender-related differences in the relationship between densitometric values of whole-body bone mineral content and lean body mass in humans between 2 and 87 years of age Bone 1998 22 6 683 690 9626409
  • Maynard LM Guo SS Chumlea WC Total-body and regional bone mineral content and areal bone mineral density in children aged 8-18 Y: the Fels longitudinal study Am J Clin Nutr 1998 68 5 1111 1117 9808230
  • Yu NY Wolfson T Middleton MS Bone marrow fat content is correlated with hepatic fat content in paediatric non-alcoholic fatter liver disease Clin Radiol 2017 72 5 e9 425
  • Pacifico L Bezzi M Lombardo C V Adipokines and C-reactive protein in relation to bone mineralization in pediatric nonalcoholic fatty liver disease[J World Journal of Gastroenterology 2013 19 25 4007 4014 23840146
  • Labayen I Ruiz J R Arenaza L Hepatic fat content and bone mineral density in children with overweight/obesity [J]. Pediatr. Res 2018 84 684 688
  • Antonella M Danilo F Elenora S Relationship between nonalcoholic steatohepatitis, PNPLA3 I148M genotype and bone mineral density in adolescents [J]. Liver International 2018 38 2301 2308
  • Campos RMS de Piano A da Silva PL The role of pro/antiinflammatory adipokines on bone metabolism in NAFLD obese adolescents: effects of long-term interdisciplinary therapy Endocrine 2012 42 1 146 156 22315014
  • Pirgon O Bilgin H Tolu I Correlation of insulin sensitivity with bone mineral status in obese adolescents with nonalcoholic fatty liver disease[J] Clinical Endocrinology 2011 75 2 189 195 21521307
  • Jae C E Yong Y D Ran Y H Vitamin D Status and Bone Mineral Density in Obese Children with Nonalcoholic Fatty Liver Disease[J] Journal of Korean Medical Science 2015 30 12 1821 1827 26713058